VALE S.A.
VALE S.A. (VALE) has a dated narrative snapshot, but its priced-in model claim is temporarily suppressed because the model-solve record is unavailable or has changed.
• The counterintuitive fact sits in the averages: the trailing year's operating profit of about $13.04 billion is below the company's own five-year average of roughly $15.16 billion, so the market is discounting a below-par year rather than a peak one. • One external variable dominates everything else, and it is the seaborne iron ore price set by steel demand half a world away, which is the one input this company does not get to choose. • The second-quarter financial report lands on July 30, 202
Is VALE overvalued? See what's priced in →
545 institutional managers reported holding VALE in 13F filings for the quarter ended 2026-03-31. Together they hold about 20% of the company; the top 10 hold 11%. 100 opened new positions that quarter. Held by Capital Group (American Funds), BlackRock, FMR (Fidelity), among others. On the short side, 62.2M shares were sold short as of the 2026-06-15 count, about 1% of shares outstanding (2.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
VALE has cut its share count 14.8% over the past five years. It pays a dividend, and has for 6 years running. Cash returned over the past three years: $15.35B in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.